PHARMA

PHARMA

Pharmaceutical Hydrogenation Membrane in Chile

Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Chile's Atacama Desert offers the world's best solar irradiance, targeting the lowest-cost green hydrogen globally.

Market Context

Chile

Policy

National Green Hydrogen Strategy

H₂ Target

Cheapest green hydrogen globally by 2030, 25 GW electrolyser by 2030

1

Cities

4

Industries

Ultra-Clean Hydrogen Source

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

GMP-Compatible On-Site Generation

On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.

Batch-Flexible Operation

Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.

Pharmaceutical Hydrogenation in Chile’s Hydrogen Market

Chile's Atacama Desert offers the world's best solar irradiance, targeting the lowest-cost green hydrogen globally. The country's mining sector (copper, lithium) provides both hydrogen demand and export infrastructure. Chile aims to produce the world's cheapest green hydrogen by 2030.

In a market where every cent per kg matters, IONZERA's 3x lower resistance directly reduces electricity consumption per kg of hydrogen, helping Chile achieve its target of the world's lowest-cost green hydrogen.

MiningSolar-to-H2Ammonia ExportCopper Processing
3x

Lower Resistance

20%

Thinner Profile

PERFORMANCE ADVANTAGE

Why IONZERA for Pharmaceutical Hydrogenation in Chile

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

Shipping & Logistics

Air freight from India to Santiago in 8-10 business days.

Area Resistance

3x LOWER
Area Specific Resistance ComparisonIONZERA0.09-0.1 Ω·cm²Zirfon0.30 Ω·cm²00.10.20.3 Ω·cm²~3x Lower

Thickness

20% THINNER
Membrane Thickness ComparisonIONZERA350-410 μmZirfon500 μm500 μm scale20-30%thinnerThinner membrane = More compact stacks= Higher power density

Pharmaceutical Hydrogenation Membrane in Chile Cities

Frequently Asked Questions

Why choose IONZERA for pharmaceutical hydrogenation in Chile?

IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in Chile. In a market where every cent per kg matters, IONZERA's 3x lower resistance directly reduces electricity consumption per kg of hydrogen, helping Chile achieve its target of the world's lowest-cost green hydrogen.

Why is membrane efficiency critical for Chilean green hydrogen?

Chile targets the world's cheapest green H2 leveraging Atacama solar resources. Every reduction in electricity consumption per kg of hydrogen directly lowers production costs. IONZERA's 3x lower resistance provides a meaningful efficiency advantage at this scale.

Ready to Start

Request Pharmaceutical Hydrogenation Samples for Chile

Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for Chile-based projects.

Request Sample